To COMPARE the EFFECT of TWO INSTRUMENTATION TECHNIQUES on the INCIDENCE of POST-ENDODONTIC PAIN in PATIENTS UNDERGOING ROOT CANAL TREATMENT in TEETH with IRREVERSIBLE PULPITIS
Launched by UROOJ FATIMA · Feb 18, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to compare two different techniques used during root canal treatment to see which one results in less pain afterward. Patients who have irreversible pulpitis, a painful condition affecting the pulp inside the tooth, will be treated using either the rotary crown down technique (Group A) or the manual step back technique (Group B). The study will measure the level of pain experienced by participants at several time points after the procedure, specifically at 4, 12, 24, and 48 hours.
To participate in this study, you must be between 18 and 70 years old and have a permanent posterior tooth with irreversible pulpitis. You should not have taken any pain medication within the week before the trial, and you should have no history of trauma, previous root canal treatments, or certain dental conditions. If you decide to join, you’ll receive care as part of this study, and your pain levels will be monitored to help researchers understand which treatment is more effective in reducing post-treatment discomfort. Your involvement will contribute to improving future dental care for others facing similar issues.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:1.Patients of both genders having age 18-70 years, no history of analgesics within the past 1 week ,subjects with no periapical radiolucency, teeth having completely formed tooth apex ,permanent posterior teeth with symptomatic/asymptomatic irreversible pulpitis, subjects who provided the consent for study participation
- • -
- • Exclusion Criteria: Subjects with a history of trauma, previous root canal treatment, associated systemic diseases ,pregnant females, subjects on analgesics or antibiotics, complaints of tenderness and pain within the past 5 days, extreme root curvature, calcified canals ,external or internal resorption.
- • -
About Urooj Fatima
Urooj Fatima is a dedicated clinical trial sponsor committed to advancing innovative medical research and improving patient outcomes. With a focus on oncology and chronic disease management, Urooj Fatima collaborates with leading research institutions and healthcare professionals to facilitate rigorous clinical trials that adhere to the highest ethical and regulatory standards. Driven by a passion for scientific excellence, Urooj Fatima aims to bridge the gap between research and patient care, ensuring that groundbreaking therapies reach those in need in a timely and efficient manner.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
Urooj Fatima, Post Graduate Trainee
Principal Investigator
Margalla Institute of Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported